cardiovascular
Full data from CAROLINA® outcome trial support long-term cardiovascular safety profile of Trajenta®
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA
Read MoreBoehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA
Read More